116 related articles for article (PubMed ID: 1367666)
1. Application of statistical design of experiments to the optimization of factor VIII expression by CHO cells.
Ganne V; Mignot G
Cytotechnology; 1991 Jul; 6(3):233-40. PubMed ID: 1367666
[TBL] [Abstract][Full Text] [Related]
2. Stable high-level expression of factor VIII in Chinese hamster ovary cells in improved elongation factor-1 alpha-based system.
Orlova NA; Kovnir SV; Gabibov AG; Vorobiev II
BMC Biotechnol; 2017 Mar; 17(1):33. PubMed ID: 28340620
[TBL] [Abstract][Full Text] [Related]
3. Mapping and partial characterization of proteases expressed by a CHO production cell line.
Sandberg H; Lütkemeyer D; Kuprin S; Wrangel M; Almstedt A; Persson P; Ek V; Mikaelsson M
Biotechnol Bioeng; 2006 Dec; 95(5):961-71. PubMed ID: 16897737
[TBL] [Abstract][Full Text] [Related]
4. Enhanced production of recombinant B-domain deleted factor VIII from Chinese hamster ovary cells by propionic and butyric acids.
Chun BH; Park SY; Chung N; Bang WG
Biotechnol Lett; 2003 Feb; 25(4):315-9. PubMed ID: 12882544
[TBL] [Abstract][Full Text] [Related]
5. Production of recombinant human factor VIII in different cell lines and the effect of human XBP1 co-expression.
Campos-da-Paz M; Costa CS; Quilici LS; de Carmo Simões I; Kyaw CM; Maranhão AQ; Brigido MM
Mol Biotechnol; 2008 Jun; 39(2):155-8. PubMed ID: 18327549
[TBL] [Abstract][Full Text] [Related]
6. The manufacturing process of recombinant factor VIII, recombinate.
Gomperts E; Lundblad R; Adamson R
Transfus Med Rev; 1992 Oct; 6(4):247-51. PubMed ID: 1421823
[TBL] [Abstract][Full Text] [Related]
7. Site-directed mutagenesis and expression of coagulation factors VIII and V in mammalian cells.
Pittman DD; Kaufman RJ
Methods Enzymol; 1993; 222():236-60. PubMed ID: 8412797
[No Abstract] [Full Text] [Related]
8. Optimisation of the Factor VIII yield in mammalian cell cultures by reducing the membrane bound fraction.
Kolind MP; Nørby PL; Berchtold MW; Johnsen LB
J Biotechnol; 2011 Feb; 151(4):357-62. PubMed ID: 21219947
[TBL] [Abstract][Full Text] [Related]
9. [Production of factor VIII by genetic techniques].
Neutzling O
Beitr Infusionsther; 1993; 31():38-43. PubMed ID: 7693262
[TBL] [Abstract][Full Text] [Related]
10. Low risk of inhibitor formation in haemophilia patients after a change in treatment from Chinese hamster ovary cell-produced to baby hamster kidney cell-produced recombinant factor VIII.
Singleton E; Smith J; Kavanagh M; Nolan B; White B
Thromb Haemost; 2007 Dec; 98(6):1188-92. PubMed ID: 18064312
[TBL] [Abstract][Full Text] [Related]
11. Cell culture and purification process--purity and safety testing.
Koplove HM
Ann Hematol; 1994; 68 Suppl 3(Suppl 3):S15-20. PubMed ID: 8180252
[No Abstract] [Full Text] [Related]
12. Biotechnology and the plasma fractionation industry--the impact of advances in the production of coagulation factor VIII.
Farrugia A
Australas Biotechnol; 1993; 3(1):16-20. PubMed ID: 7763537
[TBL] [Abstract][Full Text] [Related]
13. Application of a statistical design to the optimization of culture medium for recombinant interferon-gamma production by Chinese hamster ovary cells.
Castro PM; Hayter PM; Ison AP; Bull AT
Appl Microbiol Biotechnol; 1992 Oct; 38(1):84-90. PubMed ID: 1369013
[TBL] [Abstract][Full Text] [Related]
14. Design and operation of a recombinant mammalian cell manufacturing process for rFVIII.
Adamson R
Ann Hematol; 1994; 68 Suppl 3():S9-14. PubMed ID: 8180266
[No Abstract] [Full Text] [Related]
15. Perspectives on progressive strategies and recent trends in the production of recombinant human factor VIII.
Mannully ST; L N R; Pulicherla KK
Int J Biol Macromol; 2018 Nov; 119():496-504. PubMed ID: 30063930
[TBL] [Abstract][Full Text] [Related]
16. A factor VIII minigene comprising the truncated intron I of factor IX highly improves the in vitro production of factor VIII.
Plantier JL; Rodriguez MH; Enjolras N; Attali O; Négrier C
Thromb Haemost; 2001 Aug; 86(2):596-603. PubMed ID: 11522009
[TBL] [Abstract][Full Text] [Related]
17. Production of human antithrombin-III in a serum-free culture of CHO cells.
Yamauchi T; Asakura E; Amatsuji Y; Uno S; Furuta R; Tujikawa M; Tanabe T
Biosci Biotechnol Biochem; 1992 Apr; 56(4):600-4. PubMed ID: 1368211
[TBL] [Abstract][Full Text] [Related]
18. Recombinate: viral safety and final product manufacturing testing and specifications.
Lawrence J
Ann Hematol; 1994; 68 Suppl 3():S21-4. PubMed ID: 8180253
[No Abstract] [Full Text] [Related]
19. Gas sensor arrays for early detection of infection in mammalian cell culture.
Bachinger T; Riese U; Eriksson RK; Mandenius CF
Biosens Bioelectron; 2002 May; 17(5):395-403. PubMed ID: 11888730
[TBL] [Abstract][Full Text] [Related]
20. Use of a Plackett-Burman statistical design to determine the effect of selected amino acids on monoclonal antibody production in CHO cells.
González-Leal IJ; Carrillo-Cocom LM; Ramírez-Medrano A; López-Pacheco F; Bulnes-Abundis D; Webb-Vargas Y; Alvarez MM
Biotechnol Prog; 2011; 27(6):1709-17. PubMed ID: 21901863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
